Kerman University of Medical Sciences International Journal of Health Policy and Management 2322-5939 14 1 2025 12 01 Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands” 1 3 4764 10.34172/ijhpm.9248 EN Scott L. Greer School of Public Health, University of Michigan-Ann Arbor, Ann Arbor, MI, USA European Observatory on Health Systems and Policies, Brussels, Belgium Journal Article 2025 05 29 <span class="fontstyle0">Stadhouders and colleagues’ new measure answers an important question: Do strategic purchasing and managed competition redirect healthcare resources, and, if so, when, how, and to what? Applying it to the Netherlands, they find that they do not. This commentary first examines logical problems in arguments for strategic purchasing and managed competition, and then briefly reviews other evidence of their very limited success from, in particular, the Netherlands and England. It then raises the question of why strategic purchasing and managed competition continue to be advocated despite the poor logic of the arguments behind them and substantial evidence that they do not work.</span> https://www.ijhpm.com/article_4764_541030df81ef58495fac232f655b8861.pdf